News | Radiopharmaceuticals and Tracers | August 29, 2023

Carolina Breast Imaging Specialists, PLLC Is First in Nation to Adopt Groundbreaking Imagio Breast Imaging System for Breast Cancer Diagnosis

Imagio System’s unique hybrid modality helps doctors better characterize suspicious breast lesions to avoid unnecessary invasive biopsies and improve patient care.

First participant of cohort 4 of the theranostic CL04 trial investigating 64Cu/67Cu SARTATE in neuroblastoma has been treated at the highest dose cohort of 375MBq/kg body weight using NorthStar’s electron accelerator-produced Cu-67, marking a key milestone in NorthStar’s agreement to exclusively supply Cu-67 to Clarity

August 29, 2023 — Mammograms are an essential part of preventive healthcare, and when an initial review reveals a suspicious lesion, additional imaging and/or invasive breast biopsies could be the next step in diagnosis. However, breast biopsy procedures caused by false-positive assessments in the United States cost the healthcare system more than $2 billion per year[i] and cause millions of women unnecessary stress and anxiety.

Carolina Breast Imaging Specialists, PLLC in Greenville, North Carolina intends to change that as the first radiology center in the U.S.A. to adopt the recently available Imagio Breast Imaging System. Imagio uses non-invasive opto-acoustic ultrasound (OA/US) technology to provide real-time information about suspicious breast lesions, helping physicians characterize and differentiate masses that may — or may not — require more invasive diagnostic evaluation.

“We are committed to providing the best quality healthcare for the people in our community,” said Dr. Bruce Schroeder, Medical Director and CEO of Carolina Breast Imaging Specialists, PLLC. “Our adoption of innovative technologies like Imagio helps us deliver the world-class care that our patients deserve, and we are very excited to offer this extraordinary technology.”

Imagio OA/US technology combines laser optics and grayscale ultrasound to offer fused functional and anatomical breast imaging. The opto-acoustic images provide a unique blood map in and around breast masses, while the ultrasound provides a traditional anatomical image. Through the appearance or absence of two hallmark indicators of cancer — angiogenesis and deoxygenation — the Imagio OA/US Breast Imaging System is a more effective tool to help radiologists confirm or rule out malignancy compared with traditional diagnostic imaging modalities. And it does this without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.

For more information: www.senomedical.com